Related Experiment Video

Updated: May 23, 2026

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
06:43

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

[Resistance and treatment strategy of gastrointestinal stromal tumor target therapy]

Wei Lu1, Wei-qi Lu

  • 1Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China. dr.luwei@fudan.edu.cn

Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|March 29, 2012
PubMed

Insights

Gastrointestinal stromal tumors (GIST) can become resistant to tyrosine kinase inhibitors (TKI) due to gene mutations. Personalized treatment strategies are crucial for improving outcomes in drug-resistant GIST patients.

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • Gastrointestinal stromal tumors (GIST) arise from interstitial cells of Cajal (ICCs).
  • Tyrosine kinase inhibitors (TKIs) like imatinib and sunitinib are standard treatments for GIST.
  • Primary or secondary drug resistance limits TKI efficacy in some GIST cases.

Purpose of the Study:

  • To investigate the mechanisms of GIST drug resistance.
  • To highlight the importance of personalized medicine for GIST treatment.

Main Methods:

  • Analysis of gene mutation types in GIST.
  • Evaluation of secondary gene mutations contributing to resistance.

Main Results:

  • Gene mutation differences and secondary mutations are primary causes of GIST drug resistance.
  • Understanding these mutations is key to overcoming resistance.

Conclusions:

  • Drug resistance in GIST is primarily driven by specific gene mutations.
  • Individualized treatment strategies based on genetic profiling are essential for managing resistant GIST and improving patient quality of life.

More Related Videos

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...